GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026

ConferenceGalleriNeutral

AI Analysis

Summary

GRAIL will present six abstracts at the Early Detection of Cancer Conference and two abstracts at the European Society for Medical Oncology Congress in 2026, covering data from NHS-Galleri and PATHFINDER 2 trials on multi-cancer early detection.

Clinical Trial Data

Importance:4/10

Sentiment:

0.00

cancer screeningearly detectionmulti-cancerNHS-GalleriPATHFINDER 2EDCC 2026ESMO Congress 2026

Related Companies

$DFPH $MDCE $HIT $WHEN

Read the original article

Published by PR Newswire Pharma on October 5, 2026 8:01 PM

Read Original